Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

S039 - Dermatologic Surgery: Cosmetic Tips and Pearls

Sunday, February 18; 1:00 PM - 4:00 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Evaluate patients for the best cosmetic treatments.
  • Choose the most appropriate treatment for each patient.

Description

Cosmetic tips and pearls will be presented to enhance treatment options for the best cosmetic results. Topics covered will include surgery, lasers and other machines, fillers, botulinum toxins, peels etc. New techniques and pearls will be presented to make patient treatments easier.

Disclosures

  • Bertucci, Vince, MD: Allergan, Inc – C(Fees); Allergan, Inc. – A(Fees), I(Fees), SP(H); Croma-Pharma GmbH Austria – A(NC); Galderma Canada, Inc – A(Fees), SP(H); Galderma Laboratories, L.P. – A(Fees); Galderma USA – I(Fees); La Roche-Posay Laboratorie Pharmaceutique – A(Fees), SP(Fees); Merz Aesthetics – A(Fees), C(Fees), I(Fees); Revance Therapeutics, Inc. – C(Fees), I(Fees), SP(Fees); TEOXANE Laboratories – A(OB); Valeant Pharmaceuticals International – C(Fees);
  • Fabi, Sabrina G., MD: Alastin Skincare, Inc – A(H); Allergan, Inc – Speaker/Faculty Education(H); Bayer – I(Grants/Research Funding); Colorescience – I(Grants/Research Funding), Speaker/Faculty Education(H); Galderma Laboratories, LP – SP(H); Merz Aesthetics – I(Grants/Research Funding), Speaker/Faculty Education(H); Revance Therapeutics, Inc. – A(H), I(Grants/Research Funding);
  • Geronemus, Roy G., MD: Allergan, Inc – I(Grants/Research Funding); Allergan, Inc. – A(Grants/Research Funding); Cutera, Inc. – I(Grants/Research Funding); Cynosure, Inc – A(Grants/Research Funding), I(Grants/Research Funding); Cytrellis Biosystems, Inc – I(ST), SH(ST); Merz Aesthetics – I(Grants/Research Funding); Miramar Labs – I(Grants/Research Funding); Syneron Candela – A(Grants/Research Funding), I(Grants/Research Funding);
  • Glogau, Richard Gordon, MD: Allergan, Inc. – A(H), C(OB), I(Grants/Research Funding); Brickell Biotech, Inc. – I(Grants/Research Funding); Galderma USA – C(H); Gerson Lehrman Group – C(Fees); Kythera Biopharmaceuticals – A(H), I(Grants/Research Funding); Merz Aesthetics – C(OB); Q-Med – Data Safety Monitoring Board(Fees); Revance Therapeutics, Inc. – C(OB), I(OB);
  • Goodman, Gregory J., MD: Allergan, Inc. – A(Grants/Research Funding), C(OB), I(S); Galderma Laboratories, L.P. – A(H);
  • Humphrey, Shannon, MD: Allergan, Inc – Speaker/Faculty Education(H); Allergan, Inc. – A(H), I(Grants/Research Funding); Evolus, Inc. – I(H); Galderma Laboratories, L.P. – SP(H); Galderma Laboratories, LP – A(H); L'Oréal France – SP(H); Merz Aesthetics – C(H); Revance Therapeutics, Inc. – C(H), I(Grants/Research Funding), SP(H);
  • Lowe, Nicholas J., MD: no financial relationships exist with commercial interests.
  • Mariwalla, Kavita, MD: Aclaris Therapeutics Inc. – C(Fees); Galderma Argentina, S.A. – SP(Fees); Revance Therapeutics, Inc. – I(Grants/Research Funding); Skinfix, Inc. – C(Fees);
  • Monheit, Gary D., MD: Allergan, Inc. – C(H), I(Grants/Research Funding); Alphaeon – I(Grants/Research Funding); Croma-Pharma GmbH Austria – I(Grants/Research Funding); Evolus, Inc. – I(Grants/Research Funding); Galderma Laboratories, L.P. – C(H), I(Grants/Research Funding); Genentech, Inc. – SP(H); Merz Pharmaceuticals, LLC – C(H); Revance Therapeutics, Inc. – C(H), I(Grants/Research Funding); Sienna Biopharmaceuticals – I(Grants/Research Funding); Suneva Medical, Inc. – C(NC), I(Grants/Research Funding); TEOXANE Laboratories – I(Grants/Research Funding);
  • Narins, Rhoda S., MD: Allergan, Inc. – C(H); Galderma USA – I(Grants/Research Funding); Merz Aesthetics – C(H); Revance Therapeutics, Inc. – A(H); Suneva Medical, Inc. – I(Grants/Research Funding);
  • Ozog, David M., MD: Allergan, Inc – A(H); Biofrontera AG – I(Grants/Research Funding), SH(NC); DermOne – A(H); Lumenis – C(H); Medicis Pharmaceutical Corporation – I(Grants/Research Funding); miRagen Therapeutics, Inc. – I(Grants/Research Funding);
  • Shamban, Ava T., MD: Allergan, Inc – SP(H); Merz Aesthetics – SP(H); Revance Therapeutics, Inc. – I(Grants/Research Funding); Sienna Biopharmaceuticals – I(Grants/Research Funding); TEOXANE Laboratories – I(Grants/Research Funding);
  • Solish, Nowell J., MD: Allergan, Inc – A(H); Allergan, Inc. – SP(H); Galderma USA – SP(H); International hyperhidrosis society – B(H); Revance Therapeutics, Inc. – A(H);
  • Waibel, Jill S., MD: Alma Lasers – SP(H); Aquavit Pharmaceuticals – I(SO); Candela Corporation – SP(H); Cutera, Inc. – I(Grants/Research Funding); Lumenis – I(H); Lutronics, Inc. – I(Grants/Research Funding); Michelson Diagnostics Ltd. – I(EQ); Regenx – C(Grants/Research Funding); Sciton Inc. – I(Grants/Research Funding); Sebacia, Inc. – I(Grants/Research Funding); Vivosight – I(Grants/Research Funding); Zeltiq Aesthetics – SP(H);
Schedule
Sunday, February 18
1:00 PM
Dr. Monheit and Dr. Narins / Introduction
1:03 PM
Dr. Narins / • Filler tips
1:14 PM
Dr. Waibel / • Laser endpoints when treating patients • Best locations to treat wrinkles and rejuvenation with lasers • Melasma – laser and oral tranexamic acid – controversy and pearls
1:25 PM
Dr. Ozog / • Lasers Kenalog and Keloids - how to “let it flow” • Pulsed stacking of pulsed dye lasers - “getting results on challenging vessels” • Laser Assisted Delivery of Sculptra in strophic scars
1:36 PM
Dr. Goodman / • A couple of interesting treatments for treating acne scarring • How to avoid your patients going blind with fillers and how to avoid making people look strange with upper face neuromodulators
1:47 PM
Dr. Lowe / • Fractional RF- Several Indications • Injection Bruising- How to avoid • Cannulas & Needles-When & How
1:58 PM
All faculty / Discussion/Q&A
2:03 PM
Dr. Mariwalla / • Post procedure skin care - what really works. • Microneedling with PRP. Does healing time really improve? • Hair loss in women. My tips from the trenches.
2:14 PM
Dr. Glogau / • Managing facial bumps • What works in cosmetic dermatology (Pros/Cons of PRP, stem cells, collagen growth factors, etc.)
2:25 PM
Dr. Shamban / • Resurfacing • Hype vs Reality of PRP, stem cells, collagen growth factors, etc
2:36 PM
All faculty / Discussion/Q&A
2:41 PM
Dr. Fabi / • Lower Face Contouring
2:52 PM
Dr. Bertucci / Filler in: • Lips • Tear troughs • Chin
3:03 PM
Dr. Monheit / • Unusual Uses of Toxins
3:14 PM
Dr. Humphrey / •Sodium Deoxycholate beyond submental fat •Taking your glabellar neurotoxin treatments to the next level; recognizing variant patterns of glabellar anatomy and tailoring treatments for the best outco
3:25 PM
Dr. Solish / • Treating parotid glands and submandibular glands
3:36 PM
Dr. Geronemus / • Successful treatment of festoons utilizing fractional radiofrequency with microneedles • Non invasive laser treatment of actinic cheilits • Laser treatment of periorbital reticular veins
3:47 PM
All faculty / Discussion/Q&A
Event Details
  • Date
    Sunday, February 18
  • Time
    1:00 PM - 4:00 PM
  • Location
    Room 6C
  • CME Credits
    3.00
  • Type
    Restricted
Directors/Co-Directors
  • Gary D. Monheit, MD, FAAD
  • Rhoda S. Narins, MD, FAAD
Speakers
  • Ava T. Shamban, MD, FAAD
  • David M. Ozog, MD, FAAD
  • Gregory J. Goodman, MD - Handout
  • Jill S. Waibel, MD, FAAD
  • Kavita Mariwalla, MD, FAAD
  • Nicholas J. Lowe, MD, FAAD - Handout 1, Handout 2, Handout 3
  • Nowell J. Solish, MD, FAAD
  • Richard Gordon Glogau, MD, FAAD - Handout
  • Roy G. Geronemus, MD, FAAD
  • Sabrina G. Fabi, MD, FAAD
  • Shannon Humphrey, MD, FAAD
  • Vince Bertucci, MD, FAAD